This compounded preparation combines semaglutide, a once‑weekly GLP‑1 receptor agonist, with either vitamin B12 or vitamin B6 to support patient‑specific metabolic and micronutrient needs under medical supervision. Semaglutide works by enhancing glucose‑dependent insulin secretion, slowing gastric emptying, and acting on appetite centers in the brain, which has been shown in approved products to improve blood sugar control and support significant weight loss when paired with diet and lifestyle changes.
In advanced weight‑management and metabolic‑health programs, adding B12 or B6 is often intended to help support energy metabolism and address potential deficiencies as patients adopt calorie‑restricted or lower‑intake diets, though the vitamin component itself is not a weight‑loss drug. This compounded semaglutide plus B12/B6 option is typically administered by subcutaneous injection on a weekly schedule, with dose escalation, duration, and monitoring (labs, side effects, and comorbid conditions) individualized by a licensed provider as part of a comprehensive plan that includes nutrition, movement, and behavioral support.
